ANI Pharmaceuticals reported $113.48M in Gross Profit on Sales for its fiscal quarter ending in June of 2025.


Gross Profit On Sales Change Date
AbbVie USD 9.34B 1.36B Mar/2025
ANI Pharmaceuticals USD 113.48M 10.61M Jun/2025
Aurora Cannabis CAD 27.95M 18.6M Jun/2025
Canopy Growth CAD 18.04M 6.06M Jun/2025
Eli Lilly USD 13.11B 2.61B Jun/2025
Hikma Pharmaceutical USD 692M 64M Dec/2024
Knight Therapeutics CAD 45.02M 2.32M Sep/2024
Novartis USD 11.52B 1.27B Jun/2025
Perrigo USD 362.9M 29.4M Jun/2025
Sun Pharmaceuticals INR 109.71B 6.5B Jun/2025
Teva Pharmaceutical Industries USD 2.1B 188M Jun/2025